Loading...
Mirum Pharmaceuticals, Inc.
MIRM•NASDAQ
Healthcare
Biotechnology
$51.83
$-0.34(-0.65%)
Mirum Pharmaceuticals, Inc. (MIRM) Financial Performance & Income Statement Overview
Review Mirum Pharmaceuticals, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
80.76%
↑ 80.76%
Operating Income Growth
19.74%
↑ 19.74%
Net Income Growth
46.18%
↑ 46.18%
Operating Cash Flow Growth
114.55%
↑ 114.55%
Operating Margin
-20.12%
↓ 20.12%
Gross Margin
77.10%
↑ 77.10%
Net Profit Margin
-20.39%
↓ 20.39%
ROE
-33.63%
↓ 33.63%
ROIC
-13.56%
↓ 13.56%
Mirum Pharmaceuticals, Inc. (MIRM) Income Statement & Financial Overview
Review Mirum Pharmaceuticals, Inc.'s (MIRM) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $111.58M | $99.41M | $90.38M | $77.88M |
| Cost of Revenue | $23.02M | $22.78M | $20.81M | $20.23M |
| Gross Profit | $88.57M | $76.63M | $69.57M | $57.65M |
| Gross Profit Ratio | $0.79 | $0.77 | $0.77 | $0.74 |
| R&D Expenses | $46.04M | $44.03M | $31.71M | $32.67M |
| SG&A Expenses | $57.71M | $56.83M | $50.55M | $49.21M |
| Operating Expenses | $103.75M | $100.86M | $82.25M | $81.88M |
| Total Costs & Expenses | $126.77M | $123.64M | $103.06M | $102.11M |
| Interest Income | $3.02M | $3.20M | $3.47M | $3.49M |
| Interest Expense | $3.60M | $3.58M | $3.59M | $3.57M |
| Depreciation & Amortization | $6.05M | $6.06M | $6.05M | $5.85M |
| EBITDA | -$4.00M | -$14.73M | -$4.25M | -$14.58M |
| EBITDA Ratio | -$0.04 | -$0.15 | -$0.05 | -$0.19 |
| Operating Income | -$15.18M | -$24.22M | -$12.68M | -$24.23M |
| Operating Income Ratio | -$0.14 | -$0.24 | -$0.14 | -$0.31 |
| Other Income/Expenses (Net) | $1.53M | -$144000.00 | -$1.20M | $229000.00 |
| Income Before Tax | -$13.65M | -$24.37M | -$13.89M | -$24.003M |
| Income Before Tax Ratio | -$0.12 | -$0.25 | -$0.15 | -$0.31 |
| Income Tax Expense | $1.03M | -$576000.00 | $347000.00 | $635000.00 |
| Net Income | -$14.68M | -$23.79M | -$14.23M | -$24.64M |
| Net Income Ratio | -$0.13 | -$0.24 | -$0.16 | -$0.32 |
| EPS | -$0.30 | -$0.49 | -$0.30 | -$0.52 |
| Diluted EPS | -$0.30 | -$0.49 | -$0.30 | -$0.52 |
| Weighted Avg Shares Outstanding | $48.89M | $48.34M | $47.78M | $47.24M |
| Weighted Avg Shares Outstanding (Diluted) | $48.89M | $48.34M | $47.78M | $47.24M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan